Stocks
Castle Biosciences, Inc.CSTL
NASDAQHealthcareDiagnostics & Research$25.56+0.95%
Molecular diagnostics company focused on developing and commercializing gene-expression profile tests used to guide treatment decisions in oncology and other diseases. Its assays, including tests used to assess risk and management of skin cancers such as melanoma and squamous cell carcinoma, are mar...
Market Cap: $759.9M52W Range: $14.59 – $44.28
Congressional Interest in Castle Biosciences, Inc. (CSTL)
2 members of Congress have disclosed 3 trades in Castle Biosciences, Inc. (CSTL), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
3
Unique Politicians
2
Buys
2
Sells
1
Who in Congress Is Trading CSTL?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-03-15 | Josh Gottheimer | sell | $1K – $15K |
| 2020-12-23 | Gilbert Cisneros | buy | $1K – $15K |